Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). AddLife AB's share price for the quarter that ended in Mar. 2024 was kr112. AddLife AB's Shares Outstanding (EOP) for the quarter that ended in Mar. 2024 was 122 Mil. Therefore, AddLife AB's market cap for the quarter that ended in Mar. 2024 was kr13,649 Mil.
AddLife AB's quarterly market cap
increased
from Sep. 2023 (kr7,890 Mil) to Dec. 2023 (kr13,331 Mil) and
increased
from Dec. 2023 (kr13,331 Mil) to Mar. 2024 (kr13,649 Mil).
AddLife AB's annual market cap
declined
from Dec. 2021 (kr46,513 Mil) to Dec. 2022 (kr13,231 Mil) but then
increased
from Dec. 2022 (kr13,231 Mil) to Dec. 2023 (kr13,331 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. AddLife AB's Enterprise Value for Today is kr19,113 Mil.
AddLife AB Market Cap Historical Data
The historical data trend for AddLife AB's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, AddLife AB's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AddLife AB's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AddLife AB's Market Cap distribution charts can be found below:
* The bar in red indicates where AddLife AB's Market Cap falls into.
AddLife AB Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
AddLife AB's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AddLife AB (OSTO:ALIF B) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
AddLife AB Market Cap Related Terms
Thank you for viewing the detailed overview of AddLife AB's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
AddLife AB is engaged in the business of providing products, services, and advisory services. The company operates in Labtech and Medtech segments. The Labtech segment, which accounts for the majority of the company revenue, provides analytical instruments, equipment, microscopes, consumables, and reagents, as well as software support and technical service. The Medtech segment includes products related to surgery, thoracic medicine, neurology, wound care, anesthesia, intensive care, ear, nose and throat, ostomies, and home healthcare. AddLife mainly caters to hospitals & laboratories within healthcare, research, colleges, and universities, as well as the food and pharmaceutical industries. Its geographical segments are Sweden, Denmark, Finland, Norway, and Other countries.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
OSTO:ALIF B has been successfully added to your 